供卵受体新鲜胚胎移植的出生结局优于冷冻胚胎
STUDY QUESTION: For donor oocyte recipients, are birth outcomes superior for fresh versus frozen embryos? SUMMARY ANSWER: Among fresh donor oocyte recipients, fresh embryos are associated with better birth outcomes when compared with frozen embryos.…
要点
- 供卵受体新鲜胚胎移植的GBO率26.3%,冷冻胚胎为20.9%,新鲜移植更优。
- 新鲜移植活产率55.7%,高于冷冻移植的39.5%(校正RR 1.21,P<0.001)。
- 单胎出生中,两组 gestational age-adjusted birth weight 无差异。
核心结论
- 供卵受体中,新鲜胚胎移植与更好的出生结局相关。
- 现代胚胎冷冻保存未导致表型上更大的婴儿。
研究设计与样本
- 美国SART CORS国家登记库的回顾性队列,纳入2013-2015年使用新鲜供卵并发生胚胎移植的IVF周期。
- 主要结局为良好产科结局(GBO),定义为单胎、足月、活产且出生体重适于胎龄;采用广义估计方程建模。
主要发现
- 新鲜移植的GBO率为26.3%,冷冻移植为20.9%,新鲜移植获得GBO的可能性高27%(校正风险比1.27;95%CI 1.21-1.35;P<0.001)。
- 新鲜移植活产率55.7%,冷冻移植39.5%(校正风险比1.21;95%CI 1.18-1.26;P<0.001)。
- 单胎出生中,两组 gestational age-adjusted birth weight 无差异。
关键数值与推荐
- GBO定义:单胎、足月、活产且出生体重适于胎龄。
- 新鲜移植GBO率26.3% vs 冷冻20.9%,校正RR 1.27(95%CI 1.21-1.35,P<0.001)。
- 新鲜移植活产率55.7% vs 冷冻39.5%,校正RR 1.21(95%CI 1.18-1.26,P<0.001)。
临床怎么用
- 供卵受体选择新鲜胚胎移植可能获得更好的出生结局。
- 冷冻胚胎移植未增加大于胎龄儿风险,可放心使用。
局限性
- 回顾性队列结果与自体卵母细胞数据相反。
- 需在该人群中开展前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: For donor oocyte recipients, are birth outcomes superior for fresh versus frozen embryos? SUMMARY ANSWER: Among fresh donor oocyte recipients, fresh embryos are associated with better birth outcomes when compared with frozen embryos. WHAT IS KNOWN ALREADY: Frozen embryo transfer (ET) with vitrification has been associated with improved pregnancy rates, but also increased rates of large for gestational age infants. Donor oocyte recipients represent an attractive biological model to attempt to isolate the impact of embryo cryopreservation on IVF outcomes, yet there is a paucity of studies in this population. STUDY DESIGN, SIZE, DURATION: A retrospective cohort of the US national registry, the Society for Assisted Reproductive Technology Clinic Outcome Reporting System, of IVF cycles of women using fresh donor oocytes resulting in ET between 2013 and 2015. Thawed oocytes were excluded. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: Good obstetric outcome (GBO), defined as a singleton, term, live birth with appropriate for gestational age birth weight, was the primary outcome measure. Secondary outcomes included live birth, clinical pregnancy, spontaneous abortion, preterm birth, multiple births and gestational age-adjusted weight. Outcomes were modeled using the generalized estimating equation approach. MAIN RESULTS AND THE ROLE OF CHANCE: Data are from 25 387 donor oocyte cycles, in which 14 289 were fresh and 11 098 were frozen ETs. A GBO was 27% more likely in fresh ETs (26.3%) compared to frozen (20.9%) (adjusted risk ratio 1.27; 95% confidence interval (CI) 1.21-1.35; P < 0.001). Overall, fresh transfer was more likely to result in a live birth (55.7% versus 39.5%; adjusted risk ratio 1.21; 95% CI 1.18-1.26; P < 0.001). Among singleton births, there was no difference in gestational age-adjusted birth weight between groups. LIMITATION, REASONS FOR CAUTION: Our cohort findings contrast with data from autologous oocytes. Prospective studies with this population are warranted. WIDER IMPLICATIONS OF THE FINDINGS: Among donor oocyte recipients, fresh ETs may be associated with better birth outcomes. Reassuringly, given its prevalent use, modern embryo cryopreservation does not appear to result in phenotypically larger infants. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: N/A.
引用
- Roeca C, Johnson RL, Truong T, et al. Birth outcomes are superior after transfer of fresh versus frozen embryos for donor oocyte recipients. Hum Reprod. 2020. PMID: 33190157. doi:10.1093/humrep/deaa245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。